We are live on ! Find out more
RVPHW

Reviva Pharmaceuticals Warrants
RVPHW

Delisted

RVPHW was delisted on the 12th of December, 2025.

Back to rankings

16 hedge funds and large institutions have $2.53M invested in Reviva Pharmaceuticals Warrants in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $2.38M → $2.53M (+$159K)

7% more funds holding

Funds holding: 15 → 16 (+1)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HIM
HGC Investment Management
Ontario, Canada
+$17.8K
2
PC
Periscope Capital
Ontario, Canada
+$10.1K

Top Sellers

Rank Fund Capital Flow
1
OAM
Oxford Asset Management
United Kingdom
-$10.5K
2
Walleye Trading
Walleye Trading
New York
-$5.97K
3
CI
Cowen Inc
New York
-$4.09K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$2M – – –
BCM
2
BlueCrest Capital Management
Jersey
$127K – – –
GCL
3
Glazer Capital LLC
New York
$58K – – –
AA
4
AQR Arbitrage
Connecticut
$53K – – –
OAM
5
Oxford Asset Management
United Kingdom
$46K -$10.5K -52,400 -19%
Walleye Trading
6
Walleye Trading
New York
$46K -$5.97K -29,700 -11%
6CM
7
683 Capital Management
New York
$45K – – –
GCIA
8
Gabelli & Co Investment Advisers
New York
$41K – – –
GF
9
Gabelli Funds
New York
$25K – – –
PAM
10
Panagora Asset Management
Massachusetts
$24K – – –
PC
11
Periscope Capital
Ontario, Canada
$20K +$10.1K +50,300 +125%
HIM
12
HGC Investment Management
Ontario, Canada
$18K +$17.8K +88,700 New
BCM
13
Bluefin Capital Management
New York
$17K – – –
PAMP
14
Polar Asset Management Partners
Ontario, Canada
$8K – – –
CI
15
Cowen Inc
New York
$4K -$4.09K -20,351 -50%
BI
16
Bulldog Investors
New Jersey
$11 – – –

RVPHW Hedge Fund Activity: Q2 2019 in Review

16 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q2 2019, worth a combined $2.53M — up 6.7% from $2.38M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new RVPHW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was HGC Investment Management, opening a new position worth an estimated $17.8K. The largest seller was Oxford Asset Management, cutting an estimated $10.5K.

  • 16 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q2 2019, up from 15 in Q1 2019.
  • Funds reported $2.53M of Reviva Pharmaceuticals Warrants stock for Q2 2019, up 6.7% quarter-over-quarter.
  • 1 fund opened new Reviva Pharmaceuticals Warrants positions in Q2 2019 and 0 closed out, a net change of +1 holder.
  • The largest Reviva Pharmaceuticals Warrants buyer in Q2 2019 was HGC Investment Management, an estimated $17.8K added.
  • The largest Reviva Pharmaceuticals Warrants seller in Q2 2019 was Oxford Asset Management, an estimated $10.5K sold.

Based on aggregated 13F filings for Q2 2019.